About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGNCT03967600

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments ex...

Lead sponsor: University of California, San Francisco•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Kaelin Chatterley

CONTACT

415-961-3786 Kaelin.Chatterley@ucsf.edu

Sponsors

Lead Sponsor

University of California, San Francisco

Age

13 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Hidradenitis Suppurativa Patients
•1. Age 13 years or older
•2. Diagnosis of HS clinically-confirmed by a physician
•1. No history of chronic skin conditions
•2. No recent history of antibiotic use

Exclusion Criteria

•1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.
•Healthy Volunteer
•1\. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Related studies

RECRUITINGPhase 3

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT06959225 · Hidradenitis Suppurativa

RECRUITINGPhase 3

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

NCT06958211 · Hidradenitis Suppurativa

RECRUITINGPhase 1

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

NCT07049575 · Hidradenitis Suppurativa

RECRUITINGPhase 3

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

NCT06921850 · Hidradenitis Suppurativa

RECRUITINGPhase 3

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182 · Hidradenitis Suppurativa

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 4, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,000

Start dateJul 2016

Last updatedMay 4, 2026

Condition

Hidradenitis Suppurativa

Locations shown

University of California, San Francisco

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions